Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
374
-
Total 13F shares, excl. options
-
60.4M
-
Shares change
-
+147K
-
Total reported value, excl. options
-
$9.09B
-
Value change
-
+$31.9M
-
Put/Call ratio
-
0.76
-
Number of buys
-
200
-
Number of sells
-
-143
-
Price
-
$150.52
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2021
429 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2021.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 374 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.4M shares
of 66.6M outstanding shares and own 90.73% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.48M shares), VANGUARD GROUP INC (6.16M shares), FMR LLC (5.62M shares), Capital World Investors (3.43M shares), Jackson Square Partners, LLC (2.5M shares), Invesco Ltd. (1.94M shares), STATE STREET CORP (1.65M shares), Champlain Investment Partners, LLC (1.49M shares), FEDERATED HERMES, INC. (1.2M shares), and BROWN CAPITAL MANAGEMENT LLC (1.19M shares).
This table shows the top 374 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.